ISB Taps Complete Genomics for Disease Study | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Institute for Systems Biology has contracted Complete Genomics to sequence 615 complete human genomes as part of a study on neurodegenerative diseases, Complete Genomics said today.

Under the agreement, ISB will work with its academic partners to provide Complete Genomics with DNA samples from families in which multiple individuals are affected by neurodegenerative diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.